Portfolio (Quarterly)
Guide ↗
Mitsubishi UFJ Asset Management Co., Ltd.
· CIK 0001466546| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 52,762.0 | $237K | — | -1K | -2.4% | $4.50 | -5.8% |
| 142 | BTDR | BITDEER TECHNOLOGIES GROUP | Technology | 26,935.0 | $233K | — | -492.0 | -1.8% | $8.65 | +113.8% |
| 143 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 8,322.0 | $231K | — | -205.0 | -2.4% | $27.70 | +2.9% |
| 144 | PAY | PAYMENTUS HOLDINGS INC | Technology | 8,880.0 | $226K | — | -162.0 | -1.8% | $25.40 | -19.2% |
| 145 | LC | LENDINGCLUB ISSUANCE TR SER | Financial Services | 15,649.0 | $224K | — | -285.0 | -1.8% | $14.32 | +19.5% |
| 146 | MARA | MARA HOLDINGS INC | Financial Services | 26,645.0 | $217K | — | -473.0 | -1.7% | $8.16 | +68.9% |
| 147 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 3,836.0 | $217K | — | -78.0 | -2.0% | $56.49 | +0.1% |
| 148 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 23,270.0 | $217K | — | -575.0 | -2.4% | $9.31 | -7.2% |
| 149 | CIFR | CIPHER DIGITAL INC | Financial Services | 16,733.0 | $215K | — | -305.0 | -1.8% | $12.87 | +88.7% |
| 150 | EOSE | EOS ENERGY ENTERPRISES INC | Industrials | 42,849.0 | $213K | — | -1K | -2.9% | $4.96 | +34.9% |
| 151 | TD | TORONTO DOMINION BK ONT | Financial Services | 2,274.0 | $212K | — | -41.0 | -1.8% | $93.31 | +22.4% |
| 152 | — | HUT 8 CORP | — | 4,507.0 | $211K | — | -82.0 | -1.8% | $46.91 | — |
| 153 | ALLY | ALLY FINL INC | Financial Services | 5,363.0 | $210K | — | -85.0 | -1.6% | $39.23 | +8.0% |
| 154 | QTWO | Q2 HLDGS INC | Technology | 4,431.0 | $210K | — | -76.0 | -1.7% | $47.30 | -5.2% |
| 155 | LX | LEXINFINTECH HLDGS LTD | Financial Services | 95,437.0 | $208K | — | -2K | -1.8% | $2.18 | -5.0% |
| 156 | SAN | BANCO SANTANDER SA | Financial Services | 18,362.0 | $207K | — | -335.0 | -1.8% | $11.28 | +7.8% |
| 157 | — | BITFARMS LTD | — | 105,176.0 | $205K | — | -2K | -1.8% | $1.95 | — |
| 158 | STLA | STELLANTIS N.V | Consumer Cyclical | 28,816.0 | $204K | — | -901.0 | -3.0% | $7.09 | -0.1% |
| 159 | — | KASPI KZ JSC | — | 2,754.0 | $204K | — | -51.0 | -1.8% | $74.07 | — |
| 160 | NVS | NOVARTIS AG | Healthcare | 1,334.0 | $204K | — | -33.0 | -2.4% | $152.75 | -4.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
32.1%
Financial Services
12.7%
Communication Services
10.6%
Consumer Cyclical
10.2%
Healthcare
9.6%
Industrials
8.3%
Consumer Defensive
6.1%
Energy
3.6%
Utilities
2.6%
Real Estate
2.4%